Core Laboratories Inc.: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on Apr 25, 2024 and accepted by EDGAR at Apr 25, 2024, 20:38 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $129.6m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 3 months2024-01-01 to 2024-03-31 | $8.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $3.4m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $1.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | $3.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.07 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 47,703,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $5.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2024-01-01 to 2024-03-31 | $3.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2024-01-01 to 2024-03-31 | $468.0k | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2024-01-01 to 2024-03-31 | $44.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-03-31 | $14.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $229.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $588.0m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $85.5m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2024-03-31 | $160.4m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2024-03-31 | $232.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-048414. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.